Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN – Research Report), Mirati Therapeutics (MRTX – Research Report) and Opthea Limited Sponsored ADR (OPT – Research Report).
BioMarin Pharmaceutical (BMRN)
In a report released today, Leland Gershell from Oppenheimer maintained a Hold rating on BioMarin Pharmaceutical. The company’s shares closed last Tuesday at $92.06.
According to TipRanks.com, Gershell has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on BioMarin Pharmaceutical is a Moderate Buy with an average price target of $114.28, implying a 25.3% upside from current levels. In a report released today, Scotiabank also maintained a Hold rating on the stock with a $95.00 price target.
See the top stocks recommended by analysts >>
Mirati Therapeutics (MRTX)
In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Mirati Therapeutics, with a price target of $62.00. The company’s shares closed last Tuesday at $35.13, close to its 52-week low of $27.30.
According to TipRanks.com, Olson is a 5-star analyst with an average return of
Mirati Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $50.20, implying a 42.9% upside from current levels. In a report issued on September 6, Jefferies also maintained a Buy rating on the stock with a $55.00 price target.
Opthea Limited Sponsored ADR (OPT)
In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Opthea Limited Sponsored ADR, with a price target of $16.00. The company’s shares closed last Tuesday at $2.27, close to its 52-week low of $2.19.
According to TipRanks.com, Singh is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Opthea Limited Sponsored ADR with a $15.00 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BMRN:
